Business Wire

FiscalNote Acquires EU Regulatory Intelligence Leader Shungham

Jaa

FiscalNote, the Washington, D.C.-based company that dramatically improves the way organizations engage with government, today announced at the World Economic Forum in Switzerland, its acquisition of Brussels-based Shungham, a provider of systematic regulatory and legislative intelligence about European Union issues through its flagship product “EU Issue Tracker”. The move expands FiscalNote’s international leadership in the government relationship management (GRM) sector where it already provides data on regulatory and legislative issues for EU Member States and more than 20 countries worldwide. As one of the largest companies in the global market, the combined organization will provide the most comprehensive legislative and regulatory data and workflows for the EU and its Member States.

Founded in 2010 with a strong reputation for the highly-structured analysis and subject matter expertise EU regulatory issues require, Shungham’s EU Issue Tracker helps major global brands including Coca-Cola, L’Oreal, Nestle, Siemens, and BMW better understand potential regulation as it is being developed. With the most comprehensive data and analysis in a market where automated intelligence is difficult due to differing reporting requirements by country, Shungham provides a critical edge to its clients in strategic regulatory intelligence and compliance.

“As the changes in the global political landscape are giving rise to new and evolving needs in political advocacy, our clients have been asking for more actionable intelligence about the EU and its member states, along with other strategic global regions,” said Tim Hwang, co-founder and CEO of FiscalNote and a WEF Technology Pioneer. “Shungham adds a much needed human element to our AI-powered intelligence that will give our clients more insight into legislative and regulatory issues at all stages of development. As we focus at the World Economic Forum about making connections in an evolving world, this deal will empower organizations worldwide to be more effective in their engagements with government and stay aware of global updates.”

FiscalNote created the GRM category nearly two years ago with the first comprehensive engagement platform, services, and mobile application. The platform now includes data from 20 countries, and expects to rapidly expand across the world in 2018 in the hopes of one day reaching every country in the world. Shungham is the second acquisition announced in the last six months as FiscalNote attempts to grow its global presence and capabilities for its customers.

“As Brexit nears, there is a rapidly growing need for strategic intelligence on both the EU and its Members States among our clients, and joining FiscalNote gives us the ability to rapidly scale our human-curation approach and apply automation for the first time,” said Michel Ehrlich, CEO of Shungham. “The combination of our depth of intelligence in this market along with FiscalNote’s collaboration and issues management tools will allow our clients to more easily take strategic action on issues that affect their business.”

About FiscalNote

FiscalNote is a leading technology innovator at the intersection of global business & government. With offices in DC, NYC, Baton Rouge, Seoul, India, and Brussels, the company has raised more than $43 million from prominent early-stage investors including Renren, First Round Capital’s Dorm Room Fund, Green Visor Capital, MoneyToday, Visionnaire Ventures, Perle Ventures, 645 Ventures, Steve Case, Mark Cuban and Jerry Yang/AME Cloud Ventures. FiscalNote has grown to become one of the largest privately held companies in the legal analytics space, powering 21.9 million users and 1,300 law firms, legal departments and governments across its platforms. FiscalNote is revolutionizing access to legislation, regulations and court cases for organizations around the world. Organizations — from small startups and non-profits to multinational corporations — that rely on FiscalNote’s revolutionary government relationship management (GRM) and grassroots advocacy solutions include Cargill, Toyota, Intel, Johnson & Johnson, the Pharmaceutical Care Management Association, Microsoft, PhRMA, Salesforce, the Consumer Technology Association, Anthem BlueCross BlueShield, Schlumberger, Macy’s, and the National Education Association.

FiscalNote is a World Economic Forum Technology Pioneer.

Contact information

Julie Walsh, Finn Partners
202-518-6489
Julie.Walsh@FinnPartners.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 20:15Tiedote

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin

First Data Polska Deploys Inside Secure’s Mobile Payment Technology To Securely and Easily Connect to Mastercard and Visa22.10.2018 18:36Tiedote

Regulatory News: Inside Secure (Paris:INSD) (Euronext Paris: INSD), at the heart of security solutions for mobile and connected devices, today announced that First Data Polska S.A., a division of the global leader in commerce-enabling technology, selected Inside Secure technology to enable secure and flexible connections to Mastercard and Visa. First Data Polska S.A. chose Inside Secure’s Mobile Payment Client to easily integrate their solution with the Visa Token Service (VTS) and Mastercard Digital Enablement Service (MDES) – today’s major tokenization services that convert sensitive data into unique tokens that allow mobile payments to be processed. “Security and reliability are continual requirements for our services,” said Jolanta Rycerz, Member of Management Board at First Data Polska S.A. “We see Inside Secure as a valuable technology provider that enables us to easily migrate to the latest mobile payment technology and security standards. Thanks to Inside Secure, our customers,

PMI Launches Search for Next President and CEO22.10.2018 17:00Tiedote

Project Management Institute (PMI), the world’s leading professional membership organization for project managers, announced today that it has retained Heidrick & Struggles to help the organization find its next President and Chief Executive Officer (CEO). The dynamic leader shall oversee the implementation of a new strategic plan and guide the organization toward a future designed to help thousands of project professionals around the world accelerate their careers and make ideas a reality. Heidrick & Struggles is a premier provider of executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services globally. PMI will conduct a comprehensive global review of both internal and external candidates for this key position. The selected candidate will embody PMI’s core values and possess the skillsets necessary to advance the organization’s key goals. PMI’s next President and CEO will help it execute a bold new multi-year initiative d

E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 16:43Tiedote

E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t

Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 15:00Tiedote

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t

Celltrion Healthcare Hosts Forum with Patient Advocacy Groups to Provide Information on the Use of Biosimilars in Oncology22.10.2018 14:50Tiedote

To coincide with the ESMO 2018 Congress in Munich, Germany, Celltrion Healthcare invited perspective from experts including a physician and pharmacist to provide information to patient advocacy groups on the history of biosimilars, how they are tested and approved, their cost saving benefit and the wealth of clinical evidence already available on their use in order to improve understanding of biosimilars. The introduction of biosimilars in the treatment of cancer has the potential to reduce pressure on healthcare budgets and increase access to other innovative treatments or more potent regimens. This is achieved by offering more cost-effective alternatives to the reference medicinal products and by increasing competition in the market. Breast cancer is the most common cancer in women worldwide and accounts for a quarter of all cancer diagnoses in women.1 For the benefits of biosimilar use to be realised in oncology, and in the treatment of breast cancer, barriers to their uptake need t

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme